🔥 Friday 21 November 2025 Fri, 21 Nov 2025

Oceania Healthcare reports a robust interim result for the six months to September 2025, with significant earnings growth, improved sales, and a reduction in debt gearing. The company’s strategic focus on cost control, capital management, and sustainable care delivery underpins its positive outlook despite housing market headwinds.

Oceania Healthcare has posted a strong half-year turnaround with improved sales, cost savings, and reduced gearing, setting the stage for renewed growth and operational strength.

EROAD Limited reported a 3.3% revenue increase and strong free cash flow in H1 FY26, driven by ANZ market expansion despite a significant North American impairment. The company is focusing on the promising electronic Road User Charges opportunity in Australasia.